| High-Tech Gründerfonds Management GmbH. (8/1/23). "Press Release: Bind-X Secures €10 Million in Financing as Part of Its Series B Financing Round". Martinsried. |
2023-08-01 |
| ITM Isotope Technologies Munich SE. (7/31/23). "Press Release: ITM and Point Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177". Garching & Indianapolis, IN. |
2023-07-31 |
| BioNTech SE. (7/31/23). "Press Release: BioNTech Completes Acquisition of InstaDeep". Mainz. |
2023-07-31 |
| Qiagen N.V.. (7/26/23). "Press Release: Bio-Rad and Qiagen Announce Patent Settlement and Cross-licensing Agreement". Venlo. |
2023-07-26 |
| AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg. |
2023-07-26 |
| IZB Martinsried. (7/25/23). "Press Release: Viopas Venture Consulting Opens Office in the Innovation and Start-up Center Biotechnology (IZB)". Martinsried. |
2023-07-25 |
| Life Science Factory Management GmbH. (7/24/23). "Pressemitteilung: Tatjana Kasper wird neue Geschäftsführerin". Göttingen. |
2023-07-24 |
| Immatics N.V.. (7/24/23). "Press Release: Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb". Tübingen & Houston, TX. |
2023-07-24 |
| Epigenomics AG. (7/24/23). "Press Release: Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets". Berlin. |
2023-07-24 |
| Crescendo Biologics Ltd.. (7/24/23). "Press Release: Crescendo Biologics Secures $32m and Announces Expansion of CB307 Phase 1b Trial in PSMA+ Solid Tumours". Cambridge. |
2023-07-24 |
| Roche. (7/24/23). "Press Release: Roche Enters Partnership with Alnylam to Co-develop and Co-commercialise RNAi Therapeutic Zilebesiran to Treat Hypertension in Patients with High Cardiovascular Risk". Basel. |
2023-07-24 |
| CrystalsFirst GmbH. (7/24/23). "Press Release: CrystalsFirst and NexMR Join Forces to Supercharge Fragment-based Drug Discovery". |
2023-07-24 |
| Idorsia Ltd.. (7/21/23). "Press Release: Idorsia Announces a Cost Reduction Initiative to Be Implemented by the End of 2023". Allschwil. |
2023-07-21 |
| Biotechnologie Rheinland-Pfalz (MWG RLP). (7/21/23). "Pressemitteilung: Biotechnologie-Studie. Biotechnologie hat in Rheinland-Pfalz sehr gute Zukunft - Bis 2026 stehen bis zu 800 Millionen Euro bereit". |
2023-07-21 |
| Novartis AG. (7/20/23). "Press Release: Sandoz Announces Plans to Build a Biosimilar Technical Development Center in Slovenia to Support Future Growth of Biosimilar Pipeline". Basel. |
2023-07-20 |
| Idorsia Ltd.. (7/20/23). "Press Release: Idorsia Sells Its Asia Pacific (ex-China) Operations – Including Select License Rights to Products – to Sosei Heptares for a Total Consideration of CHF 400 Million". Allschwil. |
2023-07-20 |
| ADC Therapeutics S.A.. (7/20/23). "Press Release: ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of Zynlonta (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients". Lausanne. |
2023-07-20 |
| Tillotts Pharma AG. (7/20/23). "Press Release: Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis". Montréal, Munich & Rheinfelden. |
2023-07-20 |
| LimmaTech Biologics AG. (7/20/23). "Press Release: LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth". Schlieren. |
2023-07-20 |
| LimmaTech Biologics AG. (7/20/23). "Press Release: GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine". Schlieren. |
2023-07-20 |
| Biotheus Inc.. (7/19/23). "Press Release: Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech". Zhuhai. |
2023-07-19 |
| BioGeneration Ventures B.V.. (7/19/23). "Press Release: Dr. Markus Kalousek and Dr. Andrew Lightfoot Join BGV as Venture Partners". Amsterdam. |
2023-07-19 |
| Yumab GmbH. (7/19/23). "Press Release: Yumab and InScreeneX in Joint Funding Project". Braunschweig. |
2023-07-19 |
| Sophia Genetics S.A.. (7/19/23). "Press Release: Sophia Genetics Supports Sofiva Genomics to Launch New HRD Test". Boston, MA & Rolle. |
2023-07-19 |
| SGS S.A.. (7/18/23). "Press Release: SGS Appoints Géraldine Picaud as New Chief Financial Officer [Ad hoc announcement pursuant to Art. 53 LR]". |
2023-07-18 |
| Leon-Nanodrugs GmbH. (7/18/23). "Press Release: Leon-Nanodrugs Appoints Dr. Hans Frickel as Chief Executive Officer". Munich. |
2023-07-18 |
| Pieris Pharmaceuticals, Inc.. (7/18/23). "Press Release: Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring". Boston, MA. |
2023-07-18 |
| Illumina, Inc.. (7/18/23). "Press Release: The Alliance for Genomic Discovery Announces Founding Biopharma Members – AbbVie, Amgen, AstraZeneca, Bayer, and Merck". San Diego, CA. |
2023-07-18 |
| AATec Medical GmbH. (7/17/23). "Press Release: AATec Medical Announces Its Launch with EUR 2.7 Million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin". Munich. |
2023-07-17 |
| Novartis AG. (7/17/23). "Press Release: Novartis Builds on Neuroscience Pipeline and xRNA Platform Capabilities with Acquisition of DTx Pharma". Basel. |
2023-07-17 |
| High-Tech Gründerfonds Management GmbH. (7/14/23). "Press Release: Pioneering Research Projects at the 8th Life Science Pitch Day at the IZB". Martinsried. |
2023-07-14 |
| CureVac N.V.. (7/14/23). "Press Release: CureVac Announces Update to the Management Team". Tübingen & Boston, MA. |
2023-07-14 |
| BioGeneration Ventures B.V.. (7/13/23). "Press Release: BioGeneration Ventures Closes BGV Fund V at €150 Million". Naarden. |
2023-07-13 |
| High-Tech Gründerfonds Management GmbH. (7/12/23). "Press Release: Vertama Raises Seven-figure Seed Funding for Efficient, Digital Healthcare Processes". Berlin. |
2023-07-12 |
| SparingVision SAS. (7/12/23). "Press Release: SparingVision Sells Ex Vivo GIRK Technology to Tenpoint Therapeutics". Paris. |
2023-07-12 |
| Tenpoint Therapeutics Ltd.. (7/12/23). "Press Release: Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-based Therapeutics and In Vivo Reprogramming". London. |
2023-07-12 |
| Merck KGaA. (7/12/23). "Press Release: Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA". Darmstadt. |
2023-07-12 |
| ECBF Management GmbH. (7/11/23). "Press Release: Aphea.Bio, a Portfolio Company of VC Fund ECBF, Raises a Groundbreaking Series C Round of 70 Million Euros". Luxembourg. |
2023-07-11 |
| Mallia Therapeutics GmbH. (7/11/23). "Press Release: Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation". Erlangen. |
2023-07-11 |
| Evotec SE. (7/11/23). "Press Release: Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership". Hamburg. |
2023-07-11 |
| Biosynth AG. (7/11/23). "Press Release: Biosynth Expands Capabilities with Acquisition of Celares, Experts in Bioconjugation and Specialty Polymers". Staad. |
2023-07-11 |
| Zhejiang Doer Biologics Co., Ltd.. (7/10/23). "Press Release: Doer Biologics Announces License Agreement with BioNTech". Hangzhou. |
2023-07-10 |
| Inflammatix, Inc.. (7/10/23). "Press Release: Inflammatix Appoints Heiner Dreismann as New Board Member". Sunnyvale, CA. |
2023-07-10 |
| Moma Therapeutics, Inc.. (10/8/24). "Press Release: Bayer and Moma Therapeutics Enter Collaboration and License Agreement in Oncology". Berlin & Cambridge, MA. |
2023-07-10 |
| Numaferm GmbH. (7/6/23). "Press Release: Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides". |
2023-07-06 |
| BellaSeno GmbH. (7/6/23). "Press Release: BellaSeno Granted Market Access in Europe for Custom-made Bone and Pectus Excavatum Scaffolds". |
2023-07-06 |
| AiCuris Anti-infective Cures AG. (7/6/23). "Press Release: AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients". Wuppertal. |
2023-07-06 |
| TolerogenixX GmbH. (7/6/23). "Press Release: TolerogenixX Expands Phase II Immune-tolerance Trial and Closes EUR 12 million Series A Financing". |
2023-07-06 |
| Cellbox Solutions GmbH. (7/5/23). "Press Release: Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program". |
2023-07-05 |
| Golgi Neurosciences S.r.l.. (7/5/23). "Press Release: Golgi Neurosciences, a Unique Incubator to Combat Neurodegenerative Disorders, Starts Operating". Milan. |
2023-07-05 |
| NorthX Biologics. (7/3/23). "Press Release: NorthX Biologics, a Leading Nordic Development and Manufacturing Organisation Announces Acquisition of a Biologics Manufacturing Unit from Valneva". Matfors. |
2023-07-03 |
| Heidelberg Pharma AG. (6/29/23). "Press Release: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics (ad hoc announcement)". Ladenburg. |
2023-06-29 |
| Sprind GmbH. (6/29/23). "Press Release: 40 Million Euro to Develop New Bioprocessing Technologies". Leipzig. |
2023-06-29 |
| Mainz Biomed N.V.. (6/29/23). "Press Release: Mainz Biomed Secures up to $50M in New Funding". Berkeley, CA. |
2023-06-29 |
| BioNTech SE. (6/29/23). "Press Release: BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC". Mainz & Rockville, MD. |
2023-06-29 |
| MoonLake Immunotherapeutics AG. (6/28/23). "Press Release: MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares". Zug. |
2023-06-28 |
| Gleamer SAS. (6/28/23). "Press Release: Gleamer Raises €27 Million in Series B Funding Round to Expand Its AI Solutions Portfolio and Speed up International Expansion". Paris. |
2023-06-28 |
| EBAMed S.A.. (6/27/23). "Press Release: EBAMed, Swiss-Italian Company, Raises EUR 14.35 Million in Series A Funding to Develop Its Novel Image Guidance System for the Non-invasive Treatment of Ventricular Tachycardia through Proton Therapy". Zug. |
2023-06-27 |
| AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne. |
2023-06-27 |
| Astraveus SAS. (6/27/23). "Press Release: Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of Its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform". Paris. |
2023-06-27 |
| Helmholtz-Zentrum für Infektionsforschung (HZI. (6/27/23). "Press Release: Geneticist Josef Penninger Becomes New Scientific Director of the Helmholtz Centre for Infection Research". |
2023-06-27 |
| High-Tech Gründerfonds Management GmbH. (6/27/23). "Press Release: Doctorflix Secures €2 Million Seed Funding to Re-think Continuous Medical Education". |
2023-06-27 |
| Centogene N.V.. (6/27/23). "Press Release: Centogene and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE |
2023-06-27 |
| EBD Group. (6/27/23). "Press Release: BIO-Europe 2024 Is Going to Stockholm". Munich. |
2023-06-27 |
| Forbion Capital Partners. (6/27/23). "Press Release: AMG Announces Partnership with Forbion. AMG to Invest in Forbion, a Leading Pan-European Life Sciences Venture Capital and Growth Equity Firm". West Palm Beach, FL. |
2023-06-27 |
| MoonLake Immunotherapeutics AG. (6/26/23). "Press Release: MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering". Zug. |
2023-06-26 |
| High-Tech Gründerfonds Management GmbH. (6/26/23). "Press Release: Hema.to Raises €3.6M to Bring Precision Diagnostics to Immune Medicine Using AI-assisted Analysis of Single-cell Blood Data". |
2023-06-26 |
| MoonLake Immunotherapeutics AG. (6/25/23). "Press Release: MoonLake Immunotherapeutics Achieves Landmark Milestone with Positive Phase 2 Results for Nanobody Sonelokimab in Hidradenitis Suppurativa". Zug. |
2023-06-25 |
| Lunaphore Technologies S.A.. (6/22/23). "Press Release: Lunaphore to Get Acquired by Bio-Techne". Tolochenaz & Minneapolis, MN. |
2023-06-22 |
| Tagworks Pharmaceuticals B.V.. (6/22/23). "Press Release: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics". Nijmegen & Boston, MA. |
2023-06-22 |
| Memo Therapeutics AG. (6/22/23). "Press Release: Memo Therapeutics AG Starts U.S. Pivotal Phase II/III Clinical Trial with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients". Schlieren. |
2023-06-22 |
| Sarepta Therapeutics, Inc.. (6/22/23). "Press Release: Sarepta Therapeutics Announces FDA Approval of Elevidys, the First Gene Therapy to Treat Duchenne Muscular Dystrophy". Cambridge, MA. |
2023-06-22 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (6/22/23). "Press Release: Healthcare Specialist SHS Capital Invests €18 Mio in MESI Medical to Bring Digital Diagnostics to the Core of Healthcare Services". Tübingen. |
2023-06-22 |
| SandboxAQ. (6/22/23). "Press Release: SandboxAQ Announces Biopharma Molecular Simulation Division to Speed Life-Saving Drugs to Patients Through AI and Quantum Solutions". Palo Alto, CA. |
2023-06-22 |
| Nyra Health GmbH. (6/22/23). "Press Release: Nyra Health Raises €4.5m Seed Round to Advance Its Digital Neuro-therapy". Vienna, Munich & Singapore. |
2023-06-22 |
| Pieris Pharmaceuticals, Inc.. (6/21/23). "Press Release: Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study". Boston, MA. |
2023-06-21 |
| Idorsia Ltd.. (6/20/23). "Press Release: Idorsia Has Secured Bridge Financing in the Amount of CHF 75 Million (Ad hoc announcement pursuant to Art. 53 LR)". Allschwil. |
2023-06-20 |
| Upstream Bio (US). (6/20/23). "Press Release: Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases". Allschwil. |
2023-06-20 |
| Thermosome GmbH. (6/20/23). "Press Release: Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment". Munich. |
2023-06-20 |
| Santhera Pharmaceuticals Holding AG. (6/20/23). "Press Release: Santhera Grants Exclusive North America License for Vamorolone to Catalyst Pharmaceuticals in Deal Valued at up to USD 231 Million Plus Royalties [Ad hoc announcement pursuant to Art. 53 LR] |
2023-06-20 |
| Helmholtz Institute Würzburg (HIRI). (6/20/23). "Press Release: HIRI Team Receives Funding from the Helmholtz Association Toward Spinning off Leopard Biosciences". |
2023-06-20 |
| Helmholtz-Zentrum für Infektionsforschung (HZI. (6/17/23). "Press Release: IBT Lower Saxony – Lower Saxony’s Startup Incubator for Biomedical Innovation Gets Rolling". |
2023-06-17 |
| Qiagen N.V.. (6/15/23). "Press Release: Qiagen’s QuantiFERON-TB Gold Plus Shows Unique Clinical Value with CD8 Technology in New Meta-analysis of Tuberculosis Screening". Venlo. |
2023-06-15 |
| Mainz Biomed N.V.. (6/15/23). "Press Release: Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference". Mechelen. |
2023-06-15 |
| High-Tech Gründerfonds Management GmbH. (6/14/23). "Press Release: DNTox Receives €1.4 Million Seed Funding for Non-animal Testing of Chemicals". Düsseldorf. |
2023-06-14 |
| Centogene N.V.. (6/14/23). "Press Release: Centogene Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency". Cambirdge, MA, Rostock & Berlin. |
2023-06-14 |
| CRISPR Therapeutics AG. (6/13/23). "Pressemitteilung: CRISPR Therapeutics to Participate in Goldman Sachs 44th Annual Global Healthcare Conference". Zug & Cambridge, MA. |
2023-06-13 |
| Dynamic42 GmbH. (6/13/23). "Press Release: Dynamic42 Raises Mid-seven-figure Investment in Series A Financing Round". Jena. |
2023-06-13 |
| Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA. |
2023-06-13 |
| ITM Isotope Technologies Munich SE. (6/13/23). "Press Release: ITM Opens World's Largest Lutetium-177 Production Facility for Targeted Radionuclide Therapies Against Cancer". Neufahrn, Garching & Munich. |
2023-06-13 |
| Galapagos N.V.. (6/12/23). "Pressemitteilung: Galapagos Appoints Dr. Susanne Schaffert as Non-executive Independent Director to Its Board". Mechelen. |
2023-06-12 |
| Novartis AG. (6/12/23). "Pressemitteilung: Novartis Bolsters Innovative Medicines Strategy and Renal Pipeline with Agreement to Acquire Chinook Therapeutics for USD 3.2bn Upfront (USD 40 / Share)". Basel. |
2023-06-12 |
| Agilent Technologies Inc.. (6/12/23). "Press Release: Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference". Santa Clara, CA. |
2023-06-12 |
| KWS Saat SE & Co. KGaA. (6/12/23). "Press Release: KWS Partners with Vly to Further Develop Plant-based Foods". Einbeck. |
2023-06-12 |
| Gilde Healthcare Partners. (6/9/23). "Press Release: Gilde Healthcare Strengthens Investor Relations and Fundraising Team with Besmire Ahmati". Utrecht. |
2023-06-09 |
| Eckert & Ziegler Strahlen- und Medizintechnik AG. (6/8/23). "Press Release: PentixaPharm Receives BfArM-Clearance for Its Therapeutic to Conduct a Clinical Trial in Lymphoma". Würzburg. |
2023-06-08 |
| Kate Therapeutics Inc.. (6/8/23). "Press Release: Kate Therapeutics Debuts with $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases". |
2023-06-08 |
| Kate Therapeutics Inc.. (6/8/23). "Press Release: Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430". |
2023-06-08 |
| Etherna N.V.. (6/8/23). "Press Release: Steffen Helmling Joins Etherna as Chief Business Officer". Niel. |
2023-06-08 |
| Digital Science. (6/7/23). "Press Release: Digital Science Boosts Pharma Industry Support Following OntoChem Acquisition". London & Halle (Saale). |
2023-06-07 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 9 10 11 ... 40 41 42 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
